THIRD AMENDMENT TO THE CONSULTING AGREEMENT BETWEEN NEUROGENE INC. AND STUART COBB CONSULTING, LTD.

Exhibit 10.32

THIRD AMENDMENT TO THE

CONSULTING AGREEMENT BETWEEN

NEUROGENE INC. AND XXXXXX XXXX CONSULTING, LTD.

THIS THIRD AMENDMENT TO THE CONSULTING AGREEMENT (the “Amendment”) is entered and made effective as of April 1, 2022 (the “Amendment Effective Date”), by and between Neurogene Inc., a Delaware corporation having a place of business at 000 Xxxx 00^xx Xxxxxx, 0^xx Xxxxx, Xxx Xxxx, XX 00000 (“Company”) and Xxxxxx Xxxx Consulting Ltd., a limited company registered at Office 0, Xxxxxxxxxxx Xxxx, Xxxxxxx, Xxxxxxxxxx, Xxxxxxxx XX00 0XX (“Consultant”). Capitalized terms used herein but not defined herein will have the meanings ascribed to such terms in the Agreement.

WHEREAS, the parties hereto have previously entered into a Consulting Agreement (the “Agreement”) dated December 12, 2018 as amended on January 1, 2020; for the engagement of the Consultant for the provision of services as described in the Agreement; and

WHEREAS, the parties wish to amend the Agreement.

NOW THEREFORE, in consideration of the mutual covenants and agreements contained herein and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

1. The following terms of the Agreement are hereby amended.

2. Accordingly, Section 3.1 Consulting Fees of the Agreement is amended to read as follows:

The Company shall pay to the Consultant consulting fees of $28,438 per month, payable within 7 days following presentation of invoice. Payment for any partial month shall be prorated. These fees will be reviewed, upon completion of 12 months duration, solely for the purposes of evaluation inflationary impacts.

3. The fifth sentence of Schedule A Description of Services is amended to read as follows:

Provide professional opinion and thought leadership to maximize the chance of successfully developing the EXACT technology platform to treat devastating neurological conditions where other technologies are not well suited.

4. This Amendment shall be governed by and interpreted under the laws of the State of New York, without giving effect to the principles of conflicts of law of any jurisdiction.

5. Except as expressly set forth in this Amendment, the Agreement shall be unchanged and shall remain in full force and effect.

Amendment No. 3 Xxxxxx Xxxx Consulting, Ltd.
April 1, 2022		Page 1 of 2

This Amendment may be executed in one or more counterparts, each of which will be deemed an original, and all of which will constitute one and the same instrument. For purposes hereof, a facsimile or an electronic record of this Amendment, including the signature pages hereto, will be deemed to be an original.

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their duly authorized representatives as of the Amendment Effective Date.

NEUROGENE INC.						XXXXXX XXXX CONSULTING LTD.
(“Neurogene”)						(“Consultant”)
By:		/s/ Xxxxxxxxx Xxxxxx				By:		/s/ Xxxxxx Xxxx
Name:		Xxxxxxxxx Xxxxxx				Name:		Xxxxxx Xxxx
Title:		President				Title:		Chief Scientific Officer
Date:		4/7/2022				Date:		4/8/2022

Amendment No. 3 Xxxxxx Xxxx Consulting, Ltd.
April 1, 2022		Page 2 of 2